100µg
ProteoGenix
Primary Antibodies
Monoclonal Antibody
Mammalian cells
MS
Coltuximab ravtansine is directed against CD19 and is investigated to treat acute lymphoblastic leukemia.
Reviews
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? * WB ELISA Sandwich ELISA IF IHC IP FC other
Did it work in your application? * Yes No
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Send us a message from the form below
First name
Last name
Email address
Lab / Company
Phone number
Message
send